Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Modified | false |
| William J. Miller | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | ●On May 20, 2025, William J. Miller, Ph.D., our Chief Executive Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Dr. Miller’s plan covers the sale of 200,000 shares of our common stock, between September 2, 2025 and March 1, 2028. Transactions under the plan are based upon pre-established dates and stock price thresholds.
|
| Name | William J. Miller |
| Title | Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 20, 2025 |
| Expiration Date | March 1, 2028 |
| Aggregate Available | 200,000 |
| Adrian Devasahayam | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | ●On June 4, 2025, Adrian Devasahayam, Ph.D., our Senior Vice President, Product Line Management, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Dr. Devasahayam’s plan covers the sale of 11,911 shares of our common stock, between September 4, 2025 and June 2, 2026. Transactions under the plan are based upon pre-established dates and stock price thresholds.
|
| Name | Adrian Devasahayam |
| Title | Senior Vice President |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 4, 2025 |
| Expiration Date | June 2, 2026 |
| Aggregate Available | 11,911 |